TrialJournal of psychopharmacology (Oxford, England)2022

The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder.

Francis M Dijkstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.